Skip to main content
Mark Moster, MD, Neurology, Philadelphia, PA, Wills Eye Hospital

MarkLMosterMD

Neurology Philadelphia, PA

Neuro-Ophthalmology

Professor of Neurology and Ophthalmology, Wills Eye Institute, Jefferson Medical College

Dr. Moster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moster's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1983 - 1984
  • UPMC Medical Education (Pittsburgh)
    UPMC Medical Education (Pittsburgh)Residency, Neurology, 1980 - 1983
  • UPMC Medical Education
    UPMC Medical EducationInternship, Internal Medicine, 1979 - 1980
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 1979

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2005 - 2026
  • NJ State Medical License
    NJ State Medical License 1989 - 2025
  • PA State Medical License
    PA State Medical License 1980 - 2024
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • GenSight Biologics Announces Publication of RESTORE Study Data Demonstrating Sustained Efficacy 3 Years After Unilateral Injection of LUMEVOQ®
    GenSight Biologics Announces Publication of RESTORE Study Data Demonstrating Sustained Efficacy 3 Years After Unilateral Injection of LUMEVOQ®August 31st, 2021
  • GenSight Biologics Reports Findings from REALITY Study and REVERSE-RESCUE Analysis Highlighting Positive Benefits from LUMEVOQ™ (GS010) Compared to LHON Natural History
    GenSight Biologics Reports Findings from REALITY Study and REVERSE-RESCUE Analysis Highlighting Positive Benefits from LUMEVOQ™ (GS010) Compared to LHON Natural HistoryDecember 11th, 2019
  • Literature Commentary
    Literature CommentarySeptember 30th, 2019
  • Join now to see all

Grant Support

  • Cerebral Cortical Mechanisms For Control Of SaccadesNational Institute Of Neurological Disorders And Stroke1990–1994

Professional Memberships

Hospital Affiliations